Aleteia logoAleteia logo
Aleteia
Saturday 05 December |
Saint of the Day: Bl. Jean-Baptiste Fouque
home iconNews
line break icon

A new hope in the fight against Parkinson's disease

IPS CELLS

CSIRO | CC

J-P Mauro - published on 09/01/17

Researchers are confident that human trials will begin before the end of 2018.

A Japanese team of researchers has found promising results in a new gene therapy treatment for Parkinson’s disease. The trials have been successful in initial animal testing and researchers are hopeful that it will also be effective on humans.

Parkinson’s disease is a long-term degenerative disorder of the central nervous system that mainly affects the motor function. Symptoms generally develop over time and include shaking, rigidity, slowness of movement and difficulty walking. Advanced stages bring on dementia, depression and emotional problems.

BBC reports that after inducing the loss of nerve cells similar to the affects of Parkinson’s disease, the team was able to use human stem cells to fix the nerve damage in test subjects.

These cells – known as induced pluripotent stem (iPS) cells — are created by genetically reprogramming ordinary adult cells, so that they revert to an embryonic-like state. In this state, they can then be coaxed to develop into many different adult cell types – in the case of this experiment, dopamine neurons.

Researchers monitored the brain function of their test subjects, which showed normal function of the replaced cells. There was concern that if rejected, the cells would turn into cancerous tumors. The team found that the quality of the donor cells, rather than the quantity, was the key

Dr. Tilo Kunath, a researcher at the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh sees the effort as promising progress against this debilitating disorder:

“Such a therapy has the potential to reverse the symptoms of Parkinson’s in patients by restoring their dopamine-producing neurons. The next stage will be to test these therapies in a first-in-human clinical trial.”

Parkinson’s disease was first clearly identified by Dr. James Parkinson in 1817. The disease existed prior to this and was known as shaking palsy. It was named for Parkinson after he published an essay identifying its characteristics.

Tags:
Health and WellnessMedicineTechnology
Support Aleteia!

If you’re reading this article, it’s thanks to the generosity of people like you, who have made Aleteia possible.

Here are some numbers:

  • 20 million users around the world read Aleteia.org every month
  • Aleteia is published every day in eight languages: English, French, Arabic, Italian, Spanish, Portuguese, Polish, and Slovenian
  • Each month, readers view more than 50 million pages
  • Nearly 4 million people follow Aleteia on social media
  • Each month, we publish 2,450 articles and around 40 videos
  • We have 60 full time staff and approximately 400 collaborators (writers, translators, photographers, etc.)

As you can imagine, these numbers represent a lot of work. We need you.

Support Aleteia with as little as $1. It only takes a minute. Thank you!

Daily prayer
And today we celebrate...




Top 10
LUXOR FILM FESTIVAL
Zoe Romanowsky
20-year-old filmmaker wins award for powerful...
FATHER JOHN FIELDS
John Burger
Priest who volunteered for COVID-19 vaccine t...
Andrea Bocelli
J-P Mauro
Andrea Bocelli to perform live Christmas conc...
STAROŚĆ, SAMOTNOŚĆ
Cerith Gardiner
5 Patron saints to help the seniors in your l...
PRAY
Philip Kosloski
4 Tips on how to evaluate your spiritual life
Eric Clapton, Luciano Pavarotti, East London Gospel Choir
J-P Mauro
Hear Clapton and Pavarotti sing a prayer to t...
See More
Newsletter
Get Aleteia delivered to your inbox. Subscribe here.